Official announcements
messages in brief
|
02/02/2011
AGES PharmMed is receiving a high number of requests to act as Reference Member State for the Mutual Recognition and Decentralised Procedure. The routine of allocating time slots for DC procedures allows better scheduling of applications and…
Recall
|
Medicines
|
26/01/2011
The marketing authorization holder has informed its supplied customers in a letter dated January 25, 2011, that cracks have been detected in the cone of some prefilled syringes. At present, there is no indication that sterility is impaired by this…
Replacement
|
Medicines
|
26/01/2011
The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed the wholesalers supplied that all batches with the old product name "Ebixa 10mg/g Oral, Solution" will be recalled and replaced by goods with the…
Recall
|
Medicines
|
05/01/2011
Two batches of the product Dianeal have been identified that may contain endotoxins. Therefore, the marketing authorization holder has decided to recall the above mentioned batches from a dialysis center supplied in Austria.
messages in brief
|
29/12/2010
At the end of 2010, the following deadlines will expire according to the Medicines Act BGBl Nr 185/1983 as amended: Inclusion of doping warning until 31.12.2010 All medicinal products concerned must contain the doping warning by 31.12.2010 (according…
Recall
|
Medicines
|
23/12/2010
The marketing authorization holder has received increased adverse reactions (aseptic peritonitis) to the above batch. Therefore, Baxter Healthcare has decided to recall this batch from those dialysis centers that were supplied with this product.
Recall
|
Medicines
|
21/12/2010
The marketing authorization holder informed its supplied customers in a fax transmission on December 20, 2010, that due to complaints on the German market regarding the unpleasant odor of the tablets, a recall would also be carried out in Austria as…
Recall
|
Medicines
|
15/12/2010
The distribution partner Croma-Pharma has informed the supplied customers by letter dated December 9, 2010, that the above mentioned batches have to be recalled due to reduced stability. The affected batches show a negative trend or Out of…
Replacement
|
Medicines
|
13/12/2010
The marketing authorization holder informed its supplied customers in a letter dated December 13, 2010, that the affected batch exhibited significant deviations in disintegration time and friability.
messages in brief
|
01/12/2010
As of 01.12.2010, the agreement between the Republic of Austria and the Government of the Principality of Liechtenstein concerning the automatic recognition in Liechtenstein of human and veterinary medicinal products authorized or registered in…